Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Apr 15;25(8):1510–1515. doi: 10.1093/nar/25.8.1510

Structure of a bis-amidinium derivative of hoechst 33258 complexed to dodecanucleotide d(CGCGAATTCGCG)2: the role of hydrogen bonding in minor groove drug-DNA recognition.

G R Clark 1, D W Boykin 1, A Czarny 1, S Neidle 1
PMCID: PMC146622  PMID: 9162901

Abstract

The crystal structure is reported of a complex between the dodecanucleotide sequence d(CGCGAATTCGCG)2and an analogue of the DNA binding drug Hoechst 33258, in which the piperazine ring has been replaced by an amidinium group and the phenol ring by a phenylamidinium group. The structure has been refined to an R factor of 19.5% at 2.2 A resolution. The drug is held in the minor groove by five strong hydrogen bonds, together with bridging water molecules at both ends. There are few other contacts with the floor of the groove, indicating a lack of isohelicity with the groove and suggesting (i) that the observed high DNA affinity of this drug is primarily due to the array of hydrogen bonds and (ii) that these more than compensate for its poor isohelicity.

Full Text

The Full Text of this article is available as a PDF (154.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abu-Daya A., Brown P. M., Fox K. R. DNA sequence preferences of several AT-selective minor groove binding ligands. Nucleic Acids Res. 1995 Sep 11;23(17):3385–3392. doi: 10.1093/nar/23.17.3385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beerman T. A., McHugh M. M., Sigmund R., Lown J. W., Rao K. E., Bathini Y. Effects of analogs of the DNA minor groove binder Hoechst 33258 on topoisomerase II and I mediated activities. Biochim Biophys Acta. 1992 May 7;1131(1):53–61. doi: 10.1016/0167-4781(92)90098-k. [DOI] [PubMed] [Google Scholar]
  3. Berman H. M., Olson W. K., Beveridge D. L., Westbrook J., Gelbin A., Demeny T., Hsieh S. H., Srinivasan A. R., Schneider B. The nucleic acid database. A comprehensive relational database of three-dimensional structures of nucleic acids. Biophys J. 1992 Sep;63(3):751–759. doi: 10.1016/S0006-3495(92)81649-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braithwaite A. W., Baguley B. C. Existence of an extended series of antitumor compounds which bind to deoxyribonucleic acid by nonintercalative means. Biochemistry. 1980 Mar 18;19(6):1101–1106. doi: 10.1021/bi00547a009. [DOI] [PubMed] [Google Scholar]
  5. Brown D. G., Sanderson M. R., Garman E., Neidle S. Crystal structure of a berenil-d(CGCAAATTTGCG) complex. An example of drug-DNA recognition based on sequence-dependent structural features. J Mol Biol. 1992 Jul 20;226(2):481–490. doi: 10.1016/0022-2836(92)90962-j. [DOI] [PubMed] [Google Scholar]
  6. Brown D. G., Sanderson M. R., Skelly J. V., Jenkins T. C., Brown T., Garman E., Stuart D. I., Neidle S. Crystal structure of a berenil-dodecanucleotide complex: the role of water in sequence-specific ligand binding. EMBO J. 1990 Apr;9(4):1329–1334. doi: 10.1002/j.1460-2075.1990.tb08242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brünger A. T., Kuriyan J., Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 1987 Jan 23;235(4787):458–460. doi: 10.1126/science.235.4787.458. [DOI] [PubMed] [Google Scholar]
  8. Carrondo M. A., Coll M., Aymami J., Wang A. H., van der Marel G. A., van Boom J. H., Rich A. Binding of a Hoechst dye to d(CGCGATATCGCG) and its influence on the conformation of the DNA fragment. Biochemistry. 1989 Sep 19;28(19):7849–7859. doi: 10.1021/bi00445a047. [DOI] [PubMed] [Google Scholar]
  9. Chen A. Y., Yu C., Gatto B., Liu L. F. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8131–8135. doi: 10.1073/pnas.90.17.8131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clark G. R., Gray E. J., Neidle S., Li Y. H., Leupin W. Isohelicity and phasing in drug--DNA sequence recognition: crystal structure of a tris(benzimidazole)--oligonucleotide complex. Biochemistry. 1996 Oct 29;35(43):13745–13752. doi: 10.1021/bi960421m. [DOI] [PubMed] [Google Scholar]
  11. Coll M., Frederick C. A., Wang A. H., Rich A. A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8385–8389. doi: 10.1073/pnas.84.23.8385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cory M., Tidwell R. R., Fairley T. A. Structure and DNA binding activity of analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) J Med Chem. 1992 Feb 7;35(3):431–438. doi: 10.1021/jm00081a003. [DOI] [PubMed] [Google Scholar]
  13. Dervan P. B. Design of sequence-specific DNA-binding molecules. Science. 1986 Apr 25;232(4749):464–471. doi: 10.1126/science.2421408. [DOI] [PubMed] [Google Scholar]
  14. Drew H. R., Dickerson R. E. Structure of a B-DNA dodecamer. III. Geometry of hydration. J Mol Biol. 1981 Sep 25;151(3):535–556. doi: 10.1016/0022-2836(81)90009-7. [DOI] [PubMed] [Google Scholar]
  15. Edwards K. J., Jenkins T. C., Neidle S. Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties. Biochemistry. 1992 Aug 11;31(31):7104–7109. doi: 10.1021/bi00146a011. [DOI] [PubMed] [Google Scholar]
  16. Goodsell D., Dickerson R. E. Isohelical analysis of DNA groove-binding drugs. J Med Chem. 1986 May;29(5):727–733. doi: 10.1021/jm00155a023. [DOI] [PubMed] [Google Scholar]
  17. Henderson D., Hurley L. H. Molecular struggle for transcriptional control. Nat Med. 1995 Jun;1(6):525–527. doi: 10.1038/nm0695-525. [DOI] [PubMed] [Google Scholar]
  18. Jenkins T. C., Lane A. N., Neidle S., Brown D. G. NMR and molecular modeling studies of the interaction of berenil and pentamidine with d(CGCAAATTTGCG)2. Eur J Biochem. 1993 May 1;213(3):1175–1184. doi: 10.1111/j.1432-1033.1993.tb17868.x. [DOI] [PubMed] [Google Scholar]
  19. Kopka M. L., Yoon C., Goodsell D., Pjura P., Dickerson R. E. Binding of an antitumor drug to DNA, Netropsin and C-G-C-G-A-A-T-T-BrC-G-C-G. J Mol Biol. 1985 Jun 25;183(4):553–563. doi: 10.1016/0022-2836(85)90171-8. [DOI] [PubMed] [Google Scholar]
  20. Laughton C. A., Tanious F., Nunn C. M., Boykin D. W., Wilson W. D., Neidle S. A crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 and 2,5-bis(4-guanylphenyl)furan, an analogue of berenil. Structural origins of enhanced DNA-binding affinity. Biochemistry. 1996 May 7;35(18):5655–5661. doi: 10.1021/bi952162r. [DOI] [PubMed] [Google Scholar]
  21. Lavery R., Sklenar H. The definition of generalized helicoidal parameters and of axis curvature for irregular nucleic acids. J Biomol Struct Dyn. 1988 Aug;6(1):63–91. doi: 10.1080/07391102.1988.10506483. [DOI] [PubMed] [Google Scholar]
  22. Lavery R., Zakrzewska K., Pullman B. Binding of non-intercalating antibiotics to B-DNA: a theoretical study taking into account nucleic acid flexibility. J Biomol Struct Dyn. 1986 Jun;3(6):1155–1170. doi: 10.1080/07391102.1986.10508492. [DOI] [PubMed] [Google Scholar]
  23. Lombardy R. L., Tanious F. A., Ramachandran K., Tidwell R. R., Wilson W. D. Synthesis and DNA interactions of benzimidazole dications which have activity against opportunistic infections. J Med Chem. 1996 Mar 29;39(7):1452–1462. doi: 10.1021/jm9507946. [DOI] [PubMed] [Google Scholar]
  24. Marky L. A., Breslauer K. J. Origins of netropsin binding affinity and specificity: correlations of thermodynamic and structural data. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4359–4363. doi: 10.1073/pnas.84.13.4359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Neidle S. Minor-groove width and accessibility in B-DNA drug and protein complexes. FEBS Lett. 1992 Feb 17;298(1):97–99. doi: 10.1016/0014-5793(92)80030-k. [DOI] [PubMed] [Google Scholar]
  26. Nunn C. M., Jenkins T. C., Neidle S. Crystal structure of d(CGCGAATTCGCG) complexed with propamidine, a short-chain homologue of the drug pentamidine. Biochemistry. 1993 Dec 21;32(50):13838–13843. doi: 10.1021/bi00213a012. [DOI] [PubMed] [Google Scholar]
  27. Nunn C. M., Neidle S. Sequence-dependent drug binding to the minor groove of DNA: crystal structure of the DNA dodecamer d(CGCAAATTTGCG)2 complexed with propamidine. J Med Chem. 1995 Jun 23;38(13):2317–2325. doi: 10.1021/jm00013a008. [DOI] [PubMed] [Google Scholar]
  28. Quintana J. R., Lipanov A. A., Dickerson R. E. Low-temperature crystallographic analyses of the binding of Hoechst 33258 to the double-helical DNA dodecamer C-G-C-G-A-A-T-T-C-G-C-G. Biochemistry. 1991 Oct 22;30(42):10294–10306. doi: 10.1021/bi00106a030. [DOI] [PubMed] [Google Scholar]
  29. Spink N., Brown D. G., Skelly J. V., Neidle S. Sequence-dependent effects in drug-DNA interaction: the crystal structure of Hoechst 33258 bound to the d(CGCAAATTTGCG)2 duplex. Nucleic Acids Res. 1994 May 11;22(9):1607–1612. doi: 10.1093/nar/22.9.1607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tabernero L., Verdaguer N., Coll M., Fita I., van der Marel G. A., van Boom J. H., Rich A., Aymamí J. Molecular structure of the A-tract DNA dodecamer d(CGCAAATTTGCG) complexed with the minor groove binding drug netropsin. Biochemistry. 1993 Aug 24;32(33):8403–8410. doi: 10.1021/bi00084a004. [DOI] [PubMed] [Google Scholar]
  31. Teng M. K., Usman N., Frederick C. A., Wang A. H. The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG). Nucleic Acids Res. 1988 Mar 25;16(6):2671–2690. doi: 10.1093/nar/16.6.2671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Trent J. O., Clark G. R., Kumar A., Wilson W. D., Boykin D. W., Hall J. E., Tidwell R. R., Blagburn B. L., Neidle S. Targeting the minor groove of DNA: crystal structures of two complexes between furan derivatives of berenil and the DNA dodecamer d(CGCGAATTCGCG)2. J Med Chem. 1996 Nov 8;39(23):4554–4562. doi: 10.1021/jm9604484. [DOI] [PubMed] [Google Scholar]
  33. Vega M. C., García Sáez I., Aymamí J., Eritja R., Van der Marel G. A., Van Boom J. H., Rich A., Coll M. Three-dimensional crystal structure of the A-tract DNA dodecamer d(CGCAAATTTGCG) complexed with the minor-groove-binding drug Hoechst 33258. Eur J Biochem. 1994 Jun 15;222(3):721–726. doi: 10.1111/j.1432-1033.1994.tb18917.x. [DOI] [PubMed] [Google Scholar]
  34. Wood A. A., Nunn C. M., Czarny A., Boykin D. W., Neidle S. Variability in DNA minor groove width recognised by ligand binding: the crystal structure of a bis-benzimidazole compound bound to the DNA duplex d(CGCGAATTCGCG)2. Nucleic Acids Res. 1995 Sep 25;23(18):3678–3684. doi: 10.1093/nar/23.18.3678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Zasedatelev A. S. Geometrical correlations useful for design of sequence-specific DNA narrow groove binding ligands. FEBS Lett. 1991 Apr 9;281(1-2):209–211. doi: 10.1016/0014-5793(91)80395-j. [DOI] [PubMed] [Google Scholar]
  36. Zimmer C., Wähnert U. Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog Biophys Mol Biol. 1986;47(1):31–112. doi: 10.1016/0079-6107(86)90005-2. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES